Repligen Buys BioLife for $1.5 Billion

Company Repligen / BioLife Solutions Event Type M&A / Acquisition Agreement Modality Cell & Gene Therapy Bioprocessing Consumables Platform CryoStor Biopreservation Media Indication Cross-Therapeutic (Cell and Gene Therapy Manufacturing) Summary Repligen agreed to acquire BioLife Solutions for approximately $1.5 billion in enterprise value, using 64%…